GRCL Short Entry and Cover On June 14th I went short GRCL. Today my target at 5.10 at the 5.00 level was hit.
0%
0%
0%
0%
0%
−1.28USD
−90.219MUSD
95.911M
About Gracell Biotechnologies Inc.
Sector
Industry
CEO
Wei Cao
Website
Headquarters
Suzhou
Employees
314
Founded
2017
ISIN
US38406L1035
Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China.
$GRCL is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies to address major industry challenges and fulfill unmet medical needs in the treatment of cancer.
The share price is ri
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
